Richelle P. Parham
Known title: DirectorCIK: 0001550078
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
ELF Launches First Fragrance, Body Care, and Skin Mist. ELF has introduced its first fragrance and body care line, adding new categories to its beauty portfolio. The company also rolled out a hypochlorous mist for skin stress relief, expanding its skin care offerings. In addition, ELF will showcase its products at the State Fair of Texas, boosting brand visibility. These moves signal the brand’s push to broaden its product range and reach new customers.
Transaction History
| BBY | ▲ Buy | Grant | 2,611 | $0 | 6/12/2026 | View on chart |
| LH | ▲ Buy | Option Exercise | 897 | — | 2/11/2026 | View on chart |
| LH | ▼ Sell | Open Market | 7,009 | $1.8M | 10/31/2025 | View on chart |
| BBY | ▲ Buy | Grant | 2,946 | $0 | 6/13/2025 | View on chart |
| LH | ▲ Buy | Option Exercise | 944 | — | 2/6/2025 | View on chart |
| BBY | ▲ Buy | Grant | 2,258 | $0 | 6/12/2024 | View on chart |
| LH | ▲ Buy | Option Exercise | 947 | — | 2/7/2024 | View on chart |
| BBY | ▲ Buy | Grant | 2,545 | $0 | 6/14/2023 | View on chart |
| LH | ▲ Buy | Option Exercise | 742 | — | 2/11/2023 | View on chart |
| BBY | ▲ Buy | Grant | 2,603 | $0 | 6/9/2022 | View on chart |
| LH | ▲ Buy | Option Exercise | 771 | — | 2/2/2022 | View on chart |
| ELF | ▲ Buy | Grant | 4,662 | $0 | 8/26/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Labcorp to Acquire OPKO Health's BioReference Assets for $722M
Labcorp has agreed to acquire select assets from OPKO Health's BioReference division for $722 million. This move expands Labcorp's capabilities in the diagnostics sector, a key area for the company's growth. The stock is currently trading near its 52-week high, reflecting investor interest in this strategic acquisition.
Labcorp to Acquire OPKO Health's BioReference Assets for $722M. Labcorp has agreed to acquire select assets from OPKO Health's BioReference division for $722 million. This move expands Labcorp's capabilities in the diagnostics sector, a key area for the company's growth. The stock is currently trading near its 52-week high, reflecting investor interest in this strategic acquisition.